DE69514928D1 - Gegen protozoen wirksamezyklische tetrapeptide - Google Patents

Gegen protozoen wirksamezyklische tetrapeptide

Info

Publication number
DE69514928D1
DE69514928D1 DE69514928T DE69514928T DE69514928D1 DE 69514928 D1 DE69514928 D1 DE 69514928D1 DE 69514928 T DE69514928 T DE 69514928T DE 69514928 T DE69514928 T DE 69514928T DE 69514928 D1 DE69514928 D1 DE 69514928D1
Authority
DE
Germany
Prior art keywords
protocoes
cyclic tetrapeptides
effective cyclic
effective
tetrapeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69514928T
Other languages
English (en)
Other versions
DE69514928T2 (de
Inventor
Christine Lange Cannova
Anne W Dombrowski
Michael A Goetz
Sandra J Rattray
Sheo Bux Singh
Jon Polishook
Gerald F Bills
Joyce A Greene
Gary K Darland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE69514928D1 publication Critical patent/DE69514928D1/de
Application granted granted Critical
Publication of DE69514928T2 publication Critical patent/DE69514928T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/77—Fusarium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
DE69514928T 1994-07-27 1995-07-24 Gegen protozoen wirksamezyklische tetrapeptide Expired - Fee Related DE69514928T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28132594A 1994-07-27 1994-07-27
US08/447,664 US5620953A (en) 1994-07-27 1995-05-23 Antiprotozoal cyclic tetrapeptides
PCT/US1995/009371 WO1996003428A1 (en) 1994-07-27 1995-07-24 Antiprotozoal cyclic tetrapeptides

Publications (2)

Publication Number Publication Date
DE69514928D1 true DE69514928D1 (de) 2000-03-09
DE69514928T2 DE69514928T2 (de) 2000-08-17

Family

ID=26960833

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69514928T Expired - Fee Related DE69514928T2 (de) 1994-07-27 1995-07-24 Gegen protozoen wirksamezyklische tetrapeptide

Country Status (9)

Country Link
US (2) US5620953A (de)
EP (1) EP0777683B1 (de)
JP (1) JPH10503368A (de)
AT (1) ATE189460T1 (de)
AU (1) AU687602B2 (de)
CA (1) CA2194999A1 (de)
CY (1) CY2183B1 (de)
DE (1) DE69514928T2 (de)
WO (1) WO1996003428A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620953A (en) * 1994-07-27 1997-04-15 Merck & Co., Inc. Antiprotozoal cyclic tetrapeptides
US6110697A (en) * 1995-09-20 2000-08-29 Merck & Co., Inc. Histone deacetylase as target for antiprotozoal agents
US5922837A (en) * 1995-09-20 1999-07-13 Merck & Co., Inc. Antiprotozoal cyclic tetrapeptides
GB9903087D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Process
AU6109600A (en) * 1999-07-23 2001-02-13 Merck & Co., Inc. Apicidin-derived cyclic tetrapeptides
WO2002088298A1 (en) * 2001-04-27 2002-11-07 The Procter & Gamble Company Compounds, compositions, and methods for controlling biofilms
EP3461488A1 (de) 2017-09-27 2019-04-03 Onxeo Kombination aus einem dbait-molekül und einem hdac-inhibitor zur behandlung von krebs
EP3461480A1 (de) 2017-09-27 2019-04-03 Onxeo Kombination von checkpoint-hemmern des dna-schädigungsantwort-zellzyklus und belinostat zur behandlung von krebs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2410658A1 (fr) * 1977-11-30 1979-06-29 Science Union & Cie Nouveau produit biologique d'origine fongique, son obtention et son application a la therapeutique
US4338303A (en) * 1980-02-04 1982-07-06 Albert Einstein College Of Medicine Of Yeshiva University Treatment of parasitic diseases
FR2503182A1 (fr) * 1981-04-07 1982-10-08 Biofarma Sa Nouvelle souche de fusarium utilisable pour la production d'antibiotiques
JPH0334991A (ja) * 1989-06-30 1991-02-14 Shionogi & Co Ltd 環状テトラペプチドおよびその製造法
CA2032559C (en) * 1989-12-28 2001-11-06 Kiyofumi Ishikawa Endothelin antagonistic cyclic pentapeptides
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
DE69225454T2 (de) * 1991-07-01 1998-10-01 Ahc Inc Bacillus Bakterium und dessen Verwendung
US5300491A (en) * 1991-10-31 1994-04-05 Apothekernes Laboratorium A.S. Treatment of protozoal infection
US5620953A (en) * 1994-07-27 1997-04-15 Merck & Co., Inc. Antiprotozoal cyclic tetrapeptides

Also Published As

Publication number Publication date
JPH10503368A (ja) 1998-03-31
CY2183B1 (en) 2002-08-23
US5861375A (en) 1999-01-19
CA2194999A1 (en) 1996-02-08
US5620953A (en) 1997-04-15
EP0777683B1 (de) 2000-02-02
AU687602B2 (en) 1998-02-26
DE69514928T2 (de) 2000-08-17
ATE189460T1 (de) 2000-02-15
WO1996003428A1 (en) 1996-02-08
EP0777683A1 (de) 1997-06-11
AU3200495A (en) 1996-02-22
EP0777683A4 (de) 1997-08-27

Similar Documents

Publication Publication Date Title
NO982310L (no) Protegriner
NO20003233D0 (no) 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler
DK0705100T3 (da) Terapeutiske substituerede guanidiner
DE69739758D1 (de) Vakzine zur behandlung von lymphomen und leukämie
ES2095926T3 (es) Cyclosporins.
MY131388A (en) Inhibitors of hiv protease useful for the treatment of aids.
ES2178036T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
DE69830751D1 (de) Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
DE69514928T2 (de) Gegen protozoen wirksamezyklische tetrapeptide
ES2159287T3 (es) Peptidos hemorreguladores.
ATE230718T1 (de) Beta-alkoxyacrylate gegen malaria
NO20005548L (no) Mykobakterieinhibitorer
DK120892D0 (da) Treatment and prophylaxis of diseases caused by parasites, fungi or bacteria
ATE222255T1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel
NO982151L (no) Hemoregulatoriske forbindelser
DE60043936D1 (de) Vorbeugung und behandlung von p. gingivalis infektion
KR940026235U (ko) 오존을 이용한 마이크 살균소독기
EA200001065A1 (ru) Применение фосфорорганических соединений для терапевтического и профилактического лечения инфекций
MX9605312A (es) Dipsipeptidos ciclicos antifungales.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee